Buprenorphine Dosing for Extended Treatment Effectiveness
Data Collection
Narcotic-Related Disorders+2
+ Mental Disorders
+ Opioid-Related Disorders
Treatment Study
Summary
This study focuses on exploring the effectiveness of a specific medication, buprenorphine, in managing opioid use. The research aims to determine if a six times daily dose of buprenorphine can lead to a longer, 120-hour dosing schedule. This study is important as it could potentially simplify treatment plans and improve the quality of life for individuals dealing with opioid dependence. During this treatment study, participants receive buprenorphine orally, six times a day. The study measures various aspects to evaluate the medication's effectiveness. These include assessing the appropriate dose, monitoring drug use, evaluating the effects of the opioid agonist, and observing any signs of opioid withdrawal. By examining these factors, the study seeks to understand the potential benefits and risks associated with this dosing schedule.
Protocol
This section provides details of the study plan, including how the study is designed and what the study is measuring.Treatment Study
Eligibility
Researchers look for people who fit a certain description, called eligibility criteria: person's general health condition or prior treatments.Any sex
Biological sex of participants that are eligible to enroll.Over 18 Years
Range of ages for which participants are eligible to join.Healthy volunteers not allowed
If individuals who are healthy and do not have the condition being studied can participate.Conditions
Pathology
Criteria
Please contact site for information.
Study Plan
Find out more about all the medication administered in this study, their detailed description and what they involve.Study Objectives
Primary Objectives
Study Centers
These are the hospitals, clinics, or research facilities where the trial is being conducted. You can find the location closest to you and its status.This study has 1 location